Product Information
EPRONTIA 25 MG/ML SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $2.5545 per ML under NDC 52652900102. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Nov 5, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/mL
Manufacturer
Azurity Pharmaceuticals Inc.NDC
52652900102
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA214679FDA Approved
11/5/2021
TE Code
AB
On Market Since
12/6/2021
Pharmacological Classes
Price Statistics
The NADAC for EPRONTIA 25 MG/ML SOLUTION has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5545 per ML |
|---|---|
| All-time high | $2.5545 (Sep 30, 2026) |
| All-time low | $2.2854 (Nov 20, 2024) |
| 52-week high | $2.5545 |
| 52-week low | $2.4771 |
| Median price | $2.4913 |
| Average price | $2.4476 |
| Largest weekly change | +9.0% (Jan 15, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Azurity Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Topiramate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPRONTIA 25 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for EPRONTIA 25 MG/ML SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $2.5545 per ML (NDC 52652900102), effective Sep 30, 2026.
How has the price of EPRONTIA 25 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for EPRONTIA 25 MG/ML SOLUTION has risen 11.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for EPRONTIA 25 MG/ML SOLUTION?
Since Apr 17, 2024, the NADAC for EPRONTIA 25 MG/ML SOLUTION has ranged from a low of $2.2854 (Nov 20, 2024) to a high of $2.5545 (Sep 30, 2026), with a median of $2.4913 per ML.
Are there cheaper alternatives to EPRONTIA 25 MG/ML SOLUTION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPRONTIA 25 MG/ML SOLUTION, is $1.5825 per ML — about 38% below EPRONTIA 25 MG/ML SOLUTION.
Who manufactures EPRONTIA 25 MG/ML SOLUTION?
EPRONTIA 25 MG/ML SOLUTION (NDC 52652900102) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.